Edition:
United States

People: HeartWare International Inc (HTWR.O)

HTWR.O on Nasdaq

57.76USD
22 Jul 2016
Change (% chg)

$0.01 (+0.02%)
Prev Close
$57.75
Open
$57.75
Day's High
$57.79
Day's Low
$57.70
Volume
177,879
Avg. Vol
542,796
52-wk High
$94.15
52-wk Low
$25.01

Harrison, Seth 

Dr. Seth Loring Harrison, M.D., is Deputy Chairman of the Board of HeartWare International, Inc. He was Chief Executive Officer of HeartWare, Inc. from July 2003 through November 2004. Dr. Harrison serves as CEO of Apple Tree Life Sciences, Inc., Chairman of the Board of the privately-held Aileron Therapeutics and CEO and Chairman of the Board of the publicly-traded Tokai Pharmaceuticals, which were founded by Apple Tree. From 1999 until it was dissolved in 2013, Dr. Harrison was Managing General Partner of Apple Tree Partners I, L.P., an early stage life sciences venture capital firm, which had been a significant stockholder of the company through early 2013. Prior to September 1999, he held senior executive positions with Oak Investment Partners, Sevin Rosen Funds and Nazem & Company. Dr. Harrison serves on the board of and chairs the Finance Committee of the International Partnership for Microbicides, a Rockefeller Foundation/Gates Foundation-sponsored public-private partnership engaged in the development of anti-HIV microbicides. Dr. Harrison received a Bachelor of Arts from Princeton University. He received his medical degree and a Masters of Business Administration from Columbia University and completed a surgery internship at Columbia Presbyterian Hospital in New York.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Charles Larkin

--

Douglas Godshall

3,721,020

Seth Harrison

--

Peter McAree

1,187,090

Jeffrey LaRose

1,163,340

Lawrence Knopf

1,076,350
As Of  30 Dec 2014